Obesity, Thyroid Function
Conditions
Keywords
Thyroid gland, bariatric surgery, weight loss, thyroid hormones, adult, morbid obesity, cohort
Brief summary
The aim is to evaluate the effect of dramatic weight loss after bariatric surgery on thyroid function (thyroid hormone levels and particulary morphological changes) in the short and long-term setting of a cross-sectional study. A particular focus will be made with regard to putting into correlation preoperative thyroid function abnormalities and postoperative changes over time with respect to the type of bariatric intervention carried out.
Detailed description
Background: Over the last decades, there has been an increase in obesity in virtually all population groups with approximately 1.6 billion adults worldwide estimated to be overweight in 2005 and 400 million of these people qualifying as being obese. Although hormonal disturbances may play a certain role in the development of obesity, more important are the possible consequences of obesity and the influence of surgically-induced rapid weight loss on overall endocrine function of these patients. Studies evaluating the effect of weight loss on thyroid function show inconsistent results. Whilst some authors have shown that weight loss after bariatric surgery may have a positive effect on thyroid dysfunction, especially in individuals with preoperative subclinical hypothyroidism 1 resulting in normalisation of TSH levels, others fail to show any significant postoperative changes. Objective: To evaluate the effect of dramatic weight loss after bariatric surgery on thyroid function (thyroid hormone levels and particularly morphological changes) in the short and long-term in the setting of a cross-sectional study. A particular focus will be made with regard to putting into correlation preoperative thyroid function abnormalities and postoperative changes over time with respect to the type of bariatric intervention carried out. Methods: BMI, thyroid hormones (TSH, fT3, fT4 levels), need for thyroxin substitution (or equivalent medication) as well as pre- and postoperative morphological changes in the thyroid gland (usually via sonography)and Leptin values will be assessed retrospectively.
Interventions
gastric banding, gastric bypass or vertical gastroplasty either open or laparoscopic or a combination of any
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients who underwent bariatric surgery between 1998 and 2007
Exclusion criteria
* age \>18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| thyroid hormone levels (change in) | preoperative, 3, 6 and 12 months postoperative |
Secondary
| Measure | Time frame |
|---|---|
| morphological changes of the thyroid gland | up to 12 months postoperatively |
Countries
Switzerland